FRA/BSX (FRA/BSX)

Frankfurt Stock Exchange: FRA/BSX · EUR

€37.5

-2.81 (-7.0%)· Recorded snapshot

Market cap	58.6B
Revenue (ttm)	18.6B
Net income (ttm)	3.1B
EPS (ttm)	€2.13
P/E (trailing)	17.6x
P/E (forward)	13.4x
Volume	1,720

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 18.6B
Net income (ttm): 3.1B
EPS (ttm): €2.13
P/E (trailing): 17.6x
P/E (forward): 13.4x
Market cap: 58.6B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E13.4

P25 n/aP50 n/aP75 n/a

Trailing P/E17.6

P25 n/aP50 n/aP75 n/a

ROE15.3

P25 n/aP50 n/aP75 n/a

ROIC11.1

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All FRA/BSX indicators

Market & fundamental data

Available fields

234

Groups with data

Currency

USD

Showing 234 of 234 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	United States
Country code	DE
Earnings date	2026-10-28
Employees	59,000
Employees change	6,000
Employees growth	11.32%
Enterprise value	EUR 69.7B
Exchange	Frankfurt Stock Exchange
Financial currency	USD
Financial report date	2026-09-30
First seen	2026-05-10
Fiscal year end	December
Founded	1979
Industry	Medical Devices
Is primary listing	No
ISIN number	US1011371077
Last earnings date	2026-10-28
Last refreshed	2026-10-28
Last stock split date	2003-11-06
Last stock split type	Forward
Market cap	EUR 58.6B
Next earnings date	2026-10-28
Price	EUR 37.49
Price currency	EUR
Sector	Healthcare
SIC code	3845
Stock price date	2026-10-28
Symbol	fra/BSX
Website	https://www.bostonscientific.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	76.84x
Average P/E ratio (3Y)	50.98x
Average P/E ratio (5Y)	62.9x
Earnings yield	5.67%
EV/Earnings	22.59x
EV/EBIT	17.89x
EV/EBITDA	13.35x
EV/FCF	21.41x
EV/Sales	3.68x
FCF / EV yield	4.67%
FCF yield	5.55%
Forward P/E	13.43x
Graham number	25.08647
Graham upside	-33.08%
Industry forward P/E	17.57x
Industry P/E	20.35x
Lynch fair value	EUR 49.32
Lynch upside	31.54%
P/(FCF - SBC) ratio	19.75x
P/(OCF - SBC) ratio	15.51x
P/B ratio	2.64x
P/E ratio	17.63x
P/FCF ratio	18.01x
P/OCF ratio	14.41x
P/S ratio	3.16x
Price/EBITDA ratio	11.53x
Sector forward P/E	14.8x
Sector P/E	39.91x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	20.6%
EBITDA margin	27.38%
Effective tax rate	4.43%
FCF margin	17.27%
Gross margin	68.94%
Operating margin	20.6%
Pretax margin	17.35%
Profit margin	16.62%
Profit per employee	EUR 52,269
Profitable quarters	23
Profitable years	5
Revenue per employee	EUR 314,479
ROA	6.19%
ROA (5Y)	4.61%
ROCE	11.08%
ROE	15.34%
ROE (5Y)	8.1%
ROIC	11.13%
ROIC (5Y)	7.52%
SBC / revenue	1.52%
Tax / revenue	0.77%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	26.63%
EPS growth (Q)	-21.5%
EPS growth (QoQ)	-34.43%
EPS growth 10Y	46.25%
EPS growth 3Y	42.32%
EPS growth 5Y	25.24%
EPS growth quarters	7
EPS growth years	3
FCF growth	4.02%
FCF growth 3Y	33.93%
FCF growth 5Y	14.35%
Gross profit growth	8.88%
Gross profit growth (Q)	-3.23%
Gross profit growth 3Y	15.2%
Gross profit growth 5Y	12.47%
Net income growth	25.48%
Net income growth (Q)	-22.91%
Net income growth (QoQ)	-35.83%
Net income growth 3Y	43.26%
Net income growth 5Y	26.04%
Net income growth quarters	7
Net income growth years	3
OCF growth	5.69%
OCF growth 10Y	13.52%
OCF growth 3Y	28.69%
OCF growth 5Y	15.09%
Operating income growth	13.05%
Operating income growth (Q)	-6.76%
Operating income growth 3Y	23.11%
Operating income growth 5Y	17.01%
Revenue growth	8.89%
Revenue growth (Q)	1.44%
Revenue growth (QoQ)	-5.59%
Revenue growth 10Y	10.04%
Revenue growth 3Y	15.27%
Revenue growth 5Y	12.93%
Revenue growth quarters	22
Revenue growth years	5

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -811.6M
Depreciation and amortization	EUR 1.3B
EBIT	EUR 3.8B
EBITDA	EUR 5.1B
EPS	EUR 2.13
Financing cash flow	EUR -860.1M
Free cash flow	EUR 3.3B
Free cash flow minus SBC	EUR 3B
Gross profit	EUR 12.8B
Income taxes	EUR 142.7M
Investing cash flow	EUR -3.2B
Net borrowing	EUR 878.1M
Net cash flow	EUR 10.8M
Net income	EUR 3.1B
Operating cash flow minus SBC	EUR 3.8B
Operating income	EUR 3.8B
Revenue	EUR 18.6B
Stock-based compensation	EUR 287.3M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	EUR 15.17
Debt / EBITDA	2.17
Debt / equity	0.5
Debt / FCF	3.42
Interest coverage	11.57
Net cash (debt)	EUR -10.6B
Net cash / market cap	-18.16%
Net debt / EBITDA	2.09
Net debt / equity	0.48
Net debt / FCF	3.27
Piotroski F-Score	5
Shareholders' equity	EUR 22.2B
Tangible book value	EUR -553M
Tangible book value per share	EUR -0.38
Total cash	EUR 474.6M
Total debt	EUR 11.1B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.48
Current ratio	1.24
Inventory turnover	2.12
Quick ratio	0.56
Working capital	EUR 1.4B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.91%
Shareholder yield	0.91%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	86.61%
10Y return CAGR	6.44%
10Y total return	86.61%
150-day SMA	EUR 42.86
15Y price change	831.05%
15Y return CAGR	16.04%
15Y total return	831.05%
1D price change	-6.97%
1M price change	-5.78%
1M total return	-5.78%
1W price change	-8.91%
1W total return	-8.91%
1Y price change	-58.14%
1Y return CAGR	-58.17%
1Y total return	-58.14%
20-day SMA	EUR 38.85
200-day SMA	EUR 48.59
20Y price change	200.33%
20Y return CAGR	5.65%
20Y total return	200.33%
3M price change	-7.24%
3M total return	-7.24%
3Y price change	-21.36%
3Y return CAGR	-7.7%
3Y total return	-21.36%
50-day SMA	EUR 39.37
50-day SMA vs 200-day SMA	50under200
52-week high	EUR 91.20
52-week high date	2025-11-14
52-week low	EUR 36.09
52-week low date	2026-10-28
5Y price change	-2.48%
5Y return CAGR	-0.5%
5Y total return	-2.48%
6M price change	-29.35%
6M total return	-29.35%
All-time high	EUR 105.00
All-time high date	2025-02-11
All-time low	EUR 3.83
All-time low date	2011-10-24
Average true range (ATR)	EUR 1.26
Average volume	187.1
Change from 52-week high	-58.89%
Change from 52-week low	3.88%
Change from all-time high	-64.76%
Change from all-time low	866.81%
Change from open	-7.68%
Day's gap	0.77%
Dollar volume	EUR 64,483
High price	EUR 40.61
Low price	EUR 36.09
Monthly RSI	27.73
Open price	EUR 40.61
Position in 52-week range	30.97%
Previous close	EUR 40.30
Price vs 150-day SMA	-13.67%
Price vs 20-day SMA	-4.75%
Price vs 200-day SMA	-23.85%
Price vs 50-day SMA	-6.02%
Relative volume	9.19
RSI	38.63
Sharpe ratio	-2
Sharpe ratio (3Y)	-0.26
Sharpe ratio (5Y)	0.02
Sortino ratio	-2.31
Sortino ratio (3Y)	-0.17
Sortino ratio (5Y)	0.21
Volume	1.7K
Weekly RSI	36.26
YTD price change	-54.32%
YTD total return	-54.32%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1.4B
Shares change (QoQ)	-1.55%
Shares change (YoY)	-0.91%
Shares held by insiders	0.18%
Shares held by institutions	93.2%

Deeper analysis on FRA/BSX

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this FRA/BSX report

Is a complete FRA/BSX research report available?

No complete published report is available for fra/BSX (FRA/BSX) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

FRA/BSX (FRA/BSX)

Price

Financial snapshot

Fair-value bridge

Latest news · FRA/BSX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All FRA/BSX indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on FRA/BSX

Frequently asked questions